Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. - Kurata K; James-Bott A; Tye MA; Yamamoto L; Samur MK; Tai YT; Dunford J; Johansson C; Senbabaoglu F; Philpott M; Palmer C; Ramasamy K; et al. (Blood cancer journal, 2023)